Magnetic device for isolation of cells and biomolecules in a microfluidic environment

• US 20050266433A1
• Filed: 03/03/2005
• Published: 12/01/2005
• Est. Priority Date: 03/03/2004
• Status: Abandoned Application

• Current Assignee: Gpb Scientific, LLC, Mehmet Toner
• Original Assignee: Mehmet Toner
• Inventors: Toner, Mehmet, Kapur, Ravi, Carvalho, Bruce L., Barber, Tom, Huang, Lotien R.
• Application Number:
  US11/071,679
• Publication Number:
  US 20050266433A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: B01L 3/5027 by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip B01L3/5023 takes precedence; micromixers B01F33/30; microreactors for synthesis B01J19/0093; microcapillary devices in general B81B1/00
• CPC Class Codes: G01N 33/54326 Magnetic particles

Abstract

The present invention features a new and useful magnetic device and methods of its use for isolation, enrichment, and purification of cells, proteins, DNA, and other molecules. In general the device includes magnetic regions or obstacles to which magnetic particles can bind. The chemical groups, i.e., capture moieties, on the surface of the magnetic particles may then be used to bind particles, e.g., cells, or molecules of interest from complex samples, and the bound species may then be selectively released for downstream collection or further analysis.

Claims

1. A device for retaining one or more desired analytes in a sample, said device comprising a first region of magnetic obstacles disposed in a channel and a plurality of magnetic particles attached to at least one of said obstacles by a magnetic interaction.

2. The device of claim 1, wherein said channel is a microfluidic channel.

3. The device of claim 1, wherein said magnetic particles comprise a capture moiety capable of binding said one or more analytes.

4. The device of claim 3, wherein said capture moiety specifically binds a first type of analyte.

5. The device of claim 4, wherein said capture moiety comprises holo-transferrin or an anti-CD71, an anti-CD36, an anti-GPA, or an anti-CD45 antibody, or a combination thereof.

6. The device of claim 1, further comprising a second region of magnetic obstacles, wherein a plurality of magnetic particles is attached by magnetic interaction to at least one of said obstacles in said second region.

7. The device of claim 6, wherein said obstacles in said first region are interspersed among said obstacles in said second region.

8. The device of claim 6, wherein said obstacles in said first region specifically bind a first type of analyte and said obstacles in said second region specifically bind a second type of analyte.

9. The device of claim 1, wherein at least a portion of said magnetic obstacles comprise a permanent magnet.

10. The device of claim 1, wherein at least a portion of said magnetic obstacles comprise a non-permanent magnet.

11. The device of claim 1, further comprising a magnetic force generator capable of producing a magnetic field in said magnetic obstacles.

12. The device of claim 11, wherein the magnetic field generator is capable of independently applying the magnetic field to one or more obstacles.

13. The device of claim 1, wherein said obstacles are ordered in a two-dimensional array.

14. The device of claim 1, wherein said obstacles are disposed such that said one or more analytes are capable of passing between said obstacles.

15. The device of claim 1, wherein said obstacles are disposed such that at least a portion of said one or more analytes cannot pass between said obstacles.

16. The device of claim 1, wherein said one or more analytes comprise a cell.

17. The device of claim 1, wherein said one or more analytes comprise a molecule.

18. A device for retaining one or more desired analytes in a sample, said device comprising a channel comprising a plurality of magnetic obstacles, wherein said obstacles comprise a plurality of magnetic particles, and said magnetic particles comprise a capture moiety capable of binding said one or more analytes.

20. The device of claim 18, wherein said channel further comprises a region of a plurality of magnetic locations and said magnetic obstacles are attached to said locations by a magnetic interaction

21. The device of claim 18, wherein said one or more analytes comprise a cell.

19. A device for retaining one or more desired analytes in a sample, said device comprising a channel comprising a plurality of magnetic obstacles, wherein said obstacles comprise a plurality of magnetic particles, and wherein said magnetic obstacles are disposed such that at least a portion of said one or more analytes cannot pass between said obstacles.

22. A method for retaining a first type of analyte in a sample, said method comprising the steps of:

(a) providing a sample comprising at least a first and a second type of analyte and a device comprising;

(i) a first region of magnetic obstacles disposed in a channel; and

(ii) a plurality of magnetic particles attached to at least one of said obstacles by a magnetic interaction; and

(b) introducing said sample into said device, wherein said first type of analyte is retained in said device by interaction with at least one of said obstacles.

24. The method of claim 22, wherein said magnetic particles are coated with a capture moiety capable of binding said first type of analyte.

25. The method of claim 22, wherein said magnetic obstacles are disposed such that at least a portion of said first type of analyte cannot pass between said obstacles.

26. The method of claim 22, wherein said first type of analyte is a particle

27. The method of claim 26, wherein said particle is a cell.

28. The method of claim 27, wherein said cell is bacterial cell, a fetal cell, or a blood cell.

29. The method of claim 22, wherein said particle is an organelle.

30. The method of claim 29, wherein said organelle is a nucleus.

31. The method of claim 22, wherein said particle is a virus.

32. The method of claim 22, wherein said first type of analyte is a molecule.

33. The method of claim 32, wherein said molecule is a nucleic acid, protein, or supramolecular complex.

34. The method of claim 22, wherein at least 60% of analytes of said first type in said sample are retained.

35. The method of claim 22, wherein at least 70% of analytes of said second type in said sample are not retained.

36. The method of claim 22, wherein said capture moiety comprises holo-transferrin or an anti-CD71, an anti-CD36, an anti-GPA, or an anti-CD45 antibody, or a combination thereof.

37. The method of claim 24, wherein said capture moiety comprises an antibody, a protein, a peptide, or a nucleic acid.

38. The method of claim 22, wherein said device further comprises a second region of magnetic obstacles having magnetic particles attached by magnetic interaction thereto, and wherein said magnetic particles attached to said obstacles in said second region are coated with a capture moiety that selectively binds a third type of analyte.

39. The method of claim 38, wherein said obstacles in said first region are interspersed among said obstacles in said second region.

40. The method of claim 22, wherein said magnetic obstacles comprise a permanent magnet.

41. The method of claim 22, wherein said magnetic obstacles comprise a non-permanent magnet.

42. The method of claim 22, wherein said device further comprises a magnetic force generator capable of producing a magnetic field in said magnetic obstacles.

43. The method of claim 42, wherein the magnetic field generator is capable of applying the magnetic field to one or more obstacles independently.

44. The method of claim 22, wherein said obstacles are ordered in a two-dimensional array.

45. The method of claim 22, further comprising contacting a labeling moiety with said first type of analyte retained in said device

46. The method of claim 22, further comprising interrupting the magnetic interaction thereby releasing said first type of analyte from said obstacles.

47. The method of claim 22, wherein said channel is a microfluidic channel.

48. The method of claim 24, wherein said first type of analyte is specifically bound to said capture moiety.

49. The method of claim 24, wherein a candidate drug compound is attached to said magnetic particles.

50. The method of claim 49, wherein said first type of analyte is a cell, and further comprising determining the effect of said candidate drug compound on said first type of cell bound to said capture moiety.

51. The method of claim 24, wherein said capture moiety comprises a cell surface receptor.

52. The method of claim 51, wherein said sample comprises candidate ligands for said cell surface receptor.

53. The method of claim 24, wherein said device further comprises a second plurality of magnetic particles attached to at least one of said obstacles by a magnetic interaction, wherein said magnetic particles are coated with a second capture moiety capable of binding said first type of analyte.

54. The method of claim 53, wherein said plurality of particles in step (a)(ii) and said second plurality of particles are disposed on the same obstacle.

23. A method for retaining a first type of analyte in a sample, said method comprising the steps of:

(a) providing a sample comprising at least a first and a second type of analyte and a device comprising a first region of magnetic obstacles disposed in a channel, wherein said obstacles comprise a plurality of magnetic particles; and

(b) introducing said sample into said device, wherein said first type of analyte is retained in said device by interaction with at least one of said obstacles.